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Abstract
Background: The prevalence of overweight and obesity (OW/OB) among adolescents worldwide
has increased since the 60 s. Spain has reached one of the highest OW/OB prevalence rates among
adolescents from European countries. The aim of this methodological paper is to describe the
design and evaluation in the EVASYON study (Development, implementation and evaluation of the
efficacy of a therapeutic programme for adolescents with OW/OB: integral education on nutrition
and physical activity).
Methods/Design: The EVASYON was planned by a multidisciplinary team to treat OW/OB in
Spanish adolescents. The EVASYON is a multi-centre study conducted in 5 hospitals in 5 Spanish
cities (Granada, Madrid, Pamplona, Santander and Zaragoza) and two hundred and four OW/OB
Spanish adolescents were recruited for this intervention. The treatment was implemented for
approximately one-year follow-up. The adolescents were treated in groups of a maximum of 10
subjects; each group had 20 visits during the treatment period in two phases: intensive during the
first 2 months (1st to 9th visits), and extensive during the last 11 months (10th to 20th visits). In order
to assess the efficacy of the treatment, 8 dimensions were measured: diet; physical activity and
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BMC Public Health 2009, 9:414 http://www.biomedcentral.com/1471-2458/9/414fitness; eating behaviour; body composition; haematological profile; metabolic profile; minerals and
vitamins; immuno-inflammatory markers. Moreover, genetic polymorphisms were also determined.
Discussion: The treatment programme developed in the EVASYON study was designed as a
national pilot study to be implemented as an effective treatment for adolescents with OW/OB into
the Spanish Health Care Service.
Background
Adolescence is characterized by important changes in
body size and composition. Obesity started to appear as a
public health problem in the last decades of the 20th cen-
tury [1]; currently acquiring epidemic dimensions. Obes-
ity is a multifactorial condition, with many biological,
genetic, social and environmental influences affecting its
development [2,3]. In most cases, obesity is the result of
inappropriate eating behaviour, which is becoming a
major dietary, psychological and social problem in devel-
oped countries [4]. A great deal of recent literature has
focused on inadequate eating and physical activity pat-
terns, especially TV watching and other types of sedentary
behaviour [5,6]. However, the development of overweight
in adolescence may depend on the prevalence of many
other obesigenic risk factors [7], such as ethnicity and
socioeconomic status [8-12]. As a result, overweight leads
to adverse short-term consequences during childhood,
such as psychosocial problems, and long-term results
have also been reported during adulthood [13,14].
Overweight prevalence among adolescents around the
world has increased since the 1960s. Approximately 14-
15% of all 15-yr-old youngsters in the United States may
be classified as obese [15]. Similarly, a dramatic increase
in the prevalence of overweight and obesity among chil-
dren and adolescents in the European Union (EU) has
occurred in the last 20 years. About 30% of European chil-
dren are overweight and approximately one quarter of
them is obese [16]. Overweight and obesity prevalence
rates in Spanish adolescents were similar to those
observed in other European countries such as Greece, Por-
tugal, England or Belgium [17,18]. However, obesity prev-
alence in some countries seems to be levelling-off [19-21].
This could be explained, in some cases, because obesity
prevalence was already very high; but, in other cases, it
could be due to the national public health efforts showing
promising positive results. In spite of these figures and to
be the prevention the first public health strategy to fight
against obesity, we cannot forget the huge rates of over-
weight children and adolescents who must be treated.
It is widely accepted that treating childhood overweight is
an important contribution to the multilevel response to
the obesity epidemic [2]. Effective treatment for most
obese children and adolescents remains elusive. Manage-
ment protocols involving behaviour modifications, fam-
ily support, and lifestyle changes are difficult to put into
practice and may require the input of multi-disciplinary
professional teams [22,23]. In fact, lifestyle changes
require a high degree of motivation and active participa-
tion from the adolescents and their relatives [1]. Weight-
loss programmes in children and adolescents have shown
a full range of results. Isolated (e.g. physical activity, sed-
entary behaviours, diet) and combined programmes have
been investigated with relevant findings [24-26]. Overall,
combined programmes tend to be more effective in chil-
dren and adolescents because beneficial modifications are
kept for long-term. On the other hand, medication or sur-
gical interventions in these ages have been considered as
a possibility in extreme cases.
The main aims of the EVASYON study (Development,
implementation and evaluation of the efficacy of a thera-
peutic programme for adolescents with overweight and
obesity: integral education on nutrition and physical
activity) were: 1) to develop a treatment programme
including education on nutrition and physical activity, 2)
to implement this programme for one year in Spanish
adolescents with overweight and obesity and 3) to evalu-
ate its efficacy.
For comparative and popularization purposes with previ-
ous and future studies, the aim of this paper was to
describe the design and evaluation methods during the
EVASYON study.
Methods/Design
Study design and sample size estimation
The design of the EVASYON Study is an interventional
study in a cohort of overweight and obese adolescents
aged 13 to 16 years. Despite the lack of control group, we
aim to assess the determinants of the treatment effective-
ness.
In order to estimate the sample size, we considered the
results obtained in the AVENA study, a multicenter evalu-
ation of the nutritional status of Spanish adolescents [27],
showed that body fat reached the greatest variance among
anthropometrical variables [17] and was thus considered
as the main variable in the EVASYON study. In order to
achieve a 2.7% reduction between the estimated mean
and the sampling mean with a statistical power equal to
90% and an alpha risk of 0.05, one hundred and fifty-Page 2 of 11
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iables correctly described and included for this sampling
size. The sampling size was increased by 25% to avoid a
reduction of the statistical significance of the results due
to possible dropouts. The current study included a nutri-
tional treatment and an educational programme on diet,
nutrition concepts and physical activity. Two hundred
and four Spanish male and female adolescents aged 13-16
years with overweight and obesity, were the target popula-
tion to be treated at 5 paediatric units in 5 hospitals from
5 different Spanish cities (Granada, Madrid, Pamplona,
Santander and Zaragoza). A pilot study was previously
carried out including 6 participants from each hospital.
This pilot study allowed us to harmonize nutrition, psy-
chology and physical activity interventional protocols.
Moreover, preliminary measurement procedures were
tested in this pilot group of adolescents.
Before starting the EVASYON programme, a screening was
performed of all candidates. Several inclusion criteria
were defined to homogenize sample characteristics. Inclu-
sion criteria in the EVASYON programme are shown in
Table 1. The EVASYON treatment programme has been
conducted in small groups from 9 to 11 patients. There-
fore, each hospital involved in the current study had to
manage at least 5 intervention groups including the pilot
study. The treatment programme was carried out in each
group during approximately one year including twenty
visits within two specific stages (Figure 1): 1) Intensive
intervention (9 visits): participants visited the hospitals
weekly for 2 months. Paediatricians explained the patients
several motivational strategies, life and time management
strategies including physical activity recommendations or
sleep time, nutritional advice, family involvement, etc. In
this stage, one-week objectives were defined; 2) Extensive
intervention (11 visits): participants visited the hospital
monthly during 11 months. In this stage, objectives for
the adolescents were to be accomplished in one month's
time.
Assessment during follow-up
Nine measurement categories were assessed: 1) Diet; 2)
Physical activity and health-related physical fitness; 3)
Psychological profile; 4) Body composition; 5) Haemato-
logical profile; 6) Biochemistry and metabolic profiles; 7)
Mineral and vitamin profile; 8) Immunological profile; 9)
Genetic profile.
All the parameters of each measurement category, exclud-
ing genetic profile were assessed at least at four points
(Figure 2): baseline (visit 1), at the end of the intensive
intervention (visit 9), at mid point of the extensive inter-
vention (visit 13), and at the end of the EVASYON treat-
ment programme (visit 20).
EVASYON study design in each hospital involved in the treatment programmeFigure 1
EVASYON study design in each hospital involved in the treatment programme.Page 3 of 11
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Dietary intake assessment methods
A trained dietician conducted face-to-face interviews with
participants and their parents (father, mother or tutor) at
the beginning of the programme and visits 1, 9, and 20
(see Figure 2). In visits 1, 9, 13, and 20 interview informa-
tion about food intake (72-h dietary record), dietary pat-
terns, and nutrition knowledge was collected in order to
evaluate fulfilment of the recommended diet as well as
changes in food intake habits during the intervention pro-
gramme.
Moreover, a semi-quantitative food-frequency question-
naire, which was previously validated in Spain [28,29],
was completed. It contained 132 food items divided into
the following categories: dairy products, meat and eggs,
fish, fruit and vegetables, legumes, potatoes and cereals,
nuts, oils and fat, sweets and beverages. For each food
item, an average portion size was specified, and partici-
pants and their parents were asked how often they had
consumed that unit throughout the previous period hav-
ing nine options for the frequency of intake (ranging from
never/almost never to at least six times per day).
Table 1: Inclusion and exclusion criteria in the EVASYON study
Inclusion criteria Exclusion criteria
1. To be 13-16 years aged 1. To consume any pharmacological treatment
2. To be overweight or obese in agreement with Cole's criteria [49] 2. Anorexia, bulimia or other eating disorder diagnosis, except binge eating 
disorder
3. To be Spanish or to have been educated in Spain
4. Do not suffer other diagnosed disease
Evaluation during the EVASYON treatment programmeFig re 2
Evaluation during the EVASYON treatment programme.Page 4 of 11
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formed into food volume/weight (in mL or g). Nutrient
intake scores were computed with and ad hoc computer
programme specifically developed to this aim. A trained
dietician updated the nutrient data bank using the latest
available information in food-composition tables from
Spain [30,31].
Physical activity and health-related physical fitness
Physical activity was assessed applying a combination of
methods. Participants in the EVASYON study wore the
ActiGraph GT1M activity monitor (ActiGraph™, LLC, Fort
Walton Beach, FL, USA). The ActiGraph GT1M is a small
and lightweight uniaxial accelerometer (3.8 × 3.7 × 1.8
cm, 27 g) validated widely in laboratory and free-living
conditions with children and adolescents [32]. According
to previous studies in Spanish adolescents [33], partici-
pants wore the monitor for 7 consecutive days and 15-s
epochs were used in each measurement [34]. The adapted
Spanish version from the Physical Activity Questionnaire
for Adolescents (PAQ-A) was also used in the study to
assess physical activity [35]. The PAQ-A measured 1 to 5
physical activity levels in each adolescent [36]. Moreover,
other questionnaires were administered to assess patterns
and determinants related to physical activity: sedentary
behaviour, physical activity stages, family influence,
change strategies, self-efficacy and environmental factors.
In the EVASYON study, health-related physical fitness was
assessed using the validated and standardized tests
included in the EUROFIT [37] and FITNESSGRAM [38]
test batteries. These methodologies have been used in the
AVENA and HELENA studies [39] to assess physical fitness
in adolescents between 13 and 16 years of age in Spain
and other European countries, respectively. The 5 fitness
tests selected for this study were:
a) Course navette or 20-m Shuttle run test
The progressive 20-m shuttle-run test published by Leger
and Lambert in 1982 and revised in 1988 [40] is one of
the most widely used field tests to assess cardiorespiratory
fitness among children and adolescents. Subjects run as
long as possible back and forth across a 20-m space at a
specified music protocol that gets 0.5 km/h faster each
minute or period. Last 0.5 period completed is the indi-
vidual score and VO2max may be estimated with the Leger
equation.
b) Handgrip strength
Subjects perform the test in a standard bipedal position
and with the arm in complete extension without touching
any part of the body with the hand-dynamometer (TKK
5101©; Takei, Tokyo, Japan). Dynamometer was adjusted
by sex and hand size for each subject [41]. Handgrip
strength test provides some results about the maximal iso-
metric force that can be generated mainly by the hand and
arm.
c) Standing broad jump
In standing position, subject jumps as far as possible try-
ing to land with both feet together. The score is the dis-
tance between the last heel-mark and the take-off line.
Standing broad jump assesses lower-limb explosive
strength.
d) 4 × 10-m shuttle-run
4 × 10-m is an adaptation of the 5 × 10-m shuttle run test
included in the EUROFIT battery but maintaining the
same characteristics. Velocity, agility and coordination are
assessed in this test. Participants run 4 × 10-m (back and
forth) as fast as possible.
e) Back-saver sit and reach
Proposed in the FITNESSGRAM battery, this test measures
the flexibility of the hamstring muscles. The test is per-
formed with a standard and sturdy box with a scale on the
top of the box. Back-saver sit and reach is similar to the
traditional sit and reach except that the measurement is
performed on one side at a time, so each side has its indi-
vidual score.
Psychological and eating behaviour assessment
The questionnaires used during the EVASYON Study were
the following:
a) AF-5 Self-Concept Questionnaire
In order to assess self-esteem, the AF-5 [42] multidimen-
sional Self-Esteem Scale appraises five personal aspects:
academic, social, emotional, family, and physical dimen-
sions.
b) Anorectic Behaviour Observation Scale (ABOS)
The ABOS scale was developed to evaluate patient's symp-
toms based on the relatives' description of the subject's
eating behaviour. This test is useful in a clinical setting for
evaluation of patients with eating disorders. The original
version [43] evaluated three factors: 1) eating behaviour,
related to weight and foods, 2) bulimic-like behaviour
and 3) hyperactivity.
c) Eating Disorder Inventory (EDI-2)
EDI-2 is a self-report instrument that assesses the cogni-
tive and behavioural characteristics commonly found in
individuals with eating disorders [44]. It is organized into
eleven subscales that contain varying numbers of items.
The subscales are as follows: drive for thinness, body dis-
satisfaction, bulimia, ineffectiveness, perfectionism, inter-
personal distrust, interoceptive awareness, maturity fears,
ascetic behaviour, impulsive behaviour and social insecu-
rity.Page 5 of 11
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The anthropometry protocol used in the EVASYON study
was identical to the standardized protocol used in the
AVENA study with more than 2000 Spanish adolescents
[45].
Each measurement was taken three times but not consec-
utively. A complete set of measurements was performed
and then repeated twice more. Weight and height are
obtained by standardized procedures. Body mass index is
calculated as weigh/height squared (kg/m2). Skinfold
thickness were measured on the left side of the body [46]
to the nearest 0.1 mm with a skinfold caliper (Caliper
Holtain; Holtain Ltd., Walles, UK) at the following sites:
1) triceps, halfway between the acromion process and the
olecranon process; 2) biceps, at the same level as the tri-
ceps skinfold, directly above the centre of the cubital
fossa; 3) subscapular, about 20 mm below the tip of the
scapula, at an angle of 45° to the lateral side of the body;
4) suprailiac, about 20 mm above the iliac crest and 20
mm towards the medial line; 5) thigh, in the midline of
the anterior aspect of the thigh, midway between the
inguinal crease and the proximal border of the patella; 6)
calf, at the level of maximum calf circumference, on the
medial aspect of the calf.
The five circumferences are measured in centimetres with
an inelastic tape to the nearest millimetre. In general, for
these measurements, the subject is in a standing position.
For measuring the arm circumference relaxed, the subject
stands relaxed with his/her side to the observer, the arm
hanging freely at the side; the tape is passed around the
arm at the level of the midpoint of the upper arm. For
measuring upper arm circumference flexed (biceps cir-
cumference) the subject contracts muscle biceps as much
as possible, and the tape is passed around the arm so that
it touches the skin surrounding the maximum circumfer-
ence. To measure the waist circumference, the tape is
applied horizontally midway between the lowest rib mar-
gin and the iliac crest, at the end of gentle expiration. The
hip circumference measurement is taken at the point
yielding the maximum circumference over the buttocks,
with the tape held in a horizontal plane. Proximal thigh
circumference is measured just below the gluteal fold and
perpendicular to its long axis; the subject stands erect with
the feet slightly apart and the body mass evenly distrib-
uted between both legs. In addition to the anthropometry
measurements, in Zaragoza and Granada, we used labora-
tory techniques. Participants in these cities (n≈80) were
assessed by bioelectrical impedance (BIA), and dual
energy X-ray absortiometry (DXA). BOD POD® measure-
ments were also performed in the Zaragoza sample.
Pubertal development was assessed according to the five
established Tanner stages [47]. Each stage describes breast
and pubic hair development in girls and genital and pubic
hair development in boys.
Blood pressure was measured using a validated digital
automatic blood pressure monitor (OMRON M6,
OMRON HEALTH CARE Co., Ltd., Kyoto, Japan) accord-
ing to the International Protocol of the European Society
of Hypertension [48].
Haematological, biochemical, metabolic, immunological and genetic 
profile
Blood collection was performed upon an empty stomach
between 8 and 10 AM, after fasting for 10 h. Health state
of human volunteers was optimal for blood sample col-
lection.
In all cases, blood was extracted from the antecubital vein
(21.5 mL). Blood collection was carried out by experi-
enced clinical staff. Blood samples were divided into aliq-
uots as follows: 1.5 mL in EDTA tube (for haematological
study and immunophenotyping of peripheral blood
cells), 10 mL in EDTA tube (for plasma extraction) and 10
mL in gel containing tube (for serum extraction). To avoid
erroneous values due to sample deterioration, blood cell
counts and differentials were analyzed in the laboratories
of each hospital that participated in this study. Within 1-
h of collection, blood was centrifuged and aliquots of
plasma or serum were stored at -80°C. Serum samples
were sent to each laboratory at convenient time intervals
(Madrid for the immunological study, Granada for the
biochemical, metabolic and vitamin studies and Pam-
plona for the genetic study). Haematological, lipidic-met-
abolic, vitamins, immunological and genetic studies were
centralized in each participating laboratory. The parame-
ters included in each of these categories are presented in
Tables 2, 3 and 4. Quality control of the assays was
assured by the Regional Health Authority, fulfilling regu-
lations for clinical hospital laboratories in Spain.
48 h urine samples were collected coinciding with the two
last days of 72 h dietary records. Subjects were given
detailed verbal and written instructions about how to col-
lect a complete 48 h urine sample and given 3 L sterile
plastic bottles. Collection began with the second urine of
the second day and ended with the first urine of the last
day of 72 h dietary record. Urine creatinine concentration
was determined by kinetic Jaffe reaction on a Cobas cen-
trifugal analyser (Roche, Montclair, NJ). Urinary Ca was
determined by atomic absorption spectrometry (Atomic
absorption spectrometer 1100B, Perkin Elmer, Norwalk,
CT, USA). Phosphorous was analysed by photocolorime-
try (Spectrophotometer PU8620 UV/VIS/NIR, Philips, Sci-
entific and Analitycal Equipment, Eindhoven, The
Netherlands). Quantitative urine control (Lyphochek®,
Bio Rad Diagnostics Group, Irvine, CA, USA) was used toPage 6 of 11
(page number not for citation purposes)
BMC Public Health 2009, 9:414 http://www.biomedcentral.com/1471-2458/9/414assess precision. Na+, Cl- and K+ were measured with an
electrolyte analyser (EMLTM 100 Electrolyte Laboratory,
Radiometer Copenhagen, Radiometer Medical A/S, Brøn-
shøj, Denmark). Urine samples were diluted 2:1 (urine:
diluent) with diluent for urine S2490 (Radiometer
Copenhagen, Radiometer Medical A/S, Brønshøj, Den-
mark). QualitycheckTM S2480 and S2470 were used as
internal standards (Radiometer, Copenhagen, Radiome-
ter Medical A/S, Brønshøj, Denmark) to assess precision.
Urine total volume and pH were also monitored.
Ethical aspects
This project followed the ethical standards recognized by
the Declaration of Helsinki (reviewed in Hong-Kong in
September 1989 and in Edinburgh, Scotland in 2000) and
the EEC Good Clinical Practice recommendations (docu-
ment 111/3976/88, July 1990), and current Spanish legis-
lation regulating clinical research in humans (Royal
Decree 561/1993 on clinical trials). The study was
approved by the Ethics Committee of each hospital that
participated in this project and by the Ethics Committee
of the Spanish Council for Scientific Research (CSIC). The
study was explained to the participants before starting,
and the volunteers, parents or tutors signed an informed
consent.
Data confidentiality
Access to the database was restricted to the researchers that
participated in this study. Therefore, the information
obtained in the study was considered as confidential,
although the sanitary authorities have full access rights for
inspection purposes.
Statistical Analysis
The studied parameters are treated considering some fixed
variability factors: gender, age, tanner, BMI classification
[49]. Attendance, parent's presence and events are consid-
ered as random variability factors. Quality control
includes a double data entry procedure in the data base.
Firstly, an assessment of missing data and the identifica-
tion of potential outliers are carried out. The statistic proc-
esses is as follows:
1) Univariate descriptive analysis, study of data distribu-
tion, basic statistics such as central and dispersion values.
The interrelationship among variables is assessed by stud-
ying the correlation coefficients on the basis of their dis-
tribution and their association to those groups defined
upon random and fixed factors. Pair comparison tests
with previous analysis of the homogeneity of variance are
Table 2: Blood biochemical and metabolic profiles.
Biochemical variables Analytical Techniques
Triglycerides, Total cholesterol, HDL-Cholesterol, HDL2/HDL3 
fraction, LDL-cholesterol
Colorimetric assay
Apolipoprotein B, A1, Lipoprotein
(a), ASP (acylation-stimulating protein)
Nephelometry, enzyme immuno assay (EIA) and radioimmuno assasy 
(RIA)
Non Esterified Free Acids (NEFA) Chromatography
Metabolical variables Analytical Techniques
Insulin, Glucose, Prealbumin, Uric acid, Homocysteine Colorimetric assays, precipitation methods and nephelometry, enzyme 
immuno assay (EIA) and radioimmuno assasy (RIA)
Oxidative state Analytical Techniques
Oxidised-LDL Fluorimetry
Malonyl-dialdehyde HPLC
Plasma total oxidative capacity Spin electron resonance spectroscopy
Vitamins Analytical Techniques
Tocopherol, retinol, vitamin C and folic acid Chromatography
Hormones Analytical Techniques
Thyrotropin (TSH), Grown hormone (GH), Follicle-stimulating 
hormone (FSH), Luteinizing hormone (LH), Adrenocorticotropin 
hormone (ACTH), Prolactin (PRL)
Human Pituitary Kit
Ghrelin, Insulin, Leptin, PYY Gut Hormone Kit
Free tyroxine (FT4) Radioimmuno assasy (RIA)Page 7 of 11
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are also performed to study the relationship among qual-
itative variables.
2) General lineal models for each point in time and as a
function of time (longitudinal data analysis). Multivariate
models are used from different perspectives: classical
regression models and continuous or categorical principal
component analysis are used to describe multivariate
interrelationship among selected variables. Also, multi-
variate analyses are used to predict the intervention suc-
cess at a selected period of time and at the end of the study
by variables that measure the health improvement of the
patients.
The analysis of the data will be done using the statistical
packages SPSS and SAS.
Table 3: Haematological and Immunological profiles.
Haematological profile Analytical Techniques
Red blood cell counts and indices
White blood cell counts and differential
Automatic cell counter (Beckman coulter)
Cell-mediated immunity Analytical Techniques
Lymphocyte subsets:CD3, CD4, CD8, CD16/56, CD45RA, CD45RO Flow Cytometry [55]
Cellular immune function: Cytokines in serum Analytical Techniques
IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, TNF-α Immunoassay (x Map technology Linco kits) (56). Human High Sensitivity 
Kit.
TGF-β Enzyme Linked Immunoabsorbent Assay (ELISA)
Humoral immunity Analytical Techniques
Lymphocyte subset CD19 Flow Cytometry [55]
Humoral function: IgG, IgA, IgM, IgE Nephelometry
Innate immunity Analytical Techniques
C3, C4 and C-reactive protein. Nephelometry
Adhesion molecules Analytical Techniques
L-selectin, ICAM-1, VCAM-1 Immunoassay (x Map technology Linco kits) Cardiovascular CVD1 Kit
E-selectin Enzyme Linked Immunoabsorbent Assay (ELISA)
Adipokines Analytical Techniques
Adiponectin, leptin Immunoassay (x Map technology Linco kits) Cardiovascular CVD1 Kit
Table 4: Genetic profile.
Genetic variables Analytical Techniques
Adiponectin gene:
A/C SNP -4034 (rs822395),
T/G SNP +45 in exon 2 (rs2241766)
G/T SNP +276 in intron 2 (rs1501299) [56]
Interleukin 6 gene:
174 G/C SNP(rs1800795) [57]
Fat mass associated gene (FTO):
rs9939609 and rs7204609 [58]
ABI prism 7000 sequence detector followed by allelic discrimination
Melanocortin 4 receptor gene (MC4R) [59] Sequencing of the entire coding region of the MC4R gene was performed on an automated DNA 
sequencer.Page 8 of 11
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The EVASYON study develops, for the first time in Spain,
a multidisciplinary treatment programme for adolescents
with overweight and obesity that is aimed at all possibly
involved areas of the individual, such as dietary habits,
physical activity and cognitive and psychological profiles,
in order to prevent the development, in an immediate
future and in the long term, of chronic diseases associated
with obesity such as diabetes, hypertension, cardiovascu-
lar diseases, metabolic syndrome, etc. Health-related
researchers who participate in this study expect that the
programme, once its efficacy has been proved, may be
applicable in any hospital or clinic from the Spanish Sys-
tem of Health with a multidisciplinary group consisting of
paediatricians, endocrinologists, psychiatrists, psycholo-
gists, physical activity specialists and dieticians.
The EVASYON study is essentially characterized for being
a multidisciplinary and multicentre project. Thus, both
the assessment of the efficacy and the protocols of the
treatment have been developed by professionals in each
of the specific fields: psychology, nutrition, physical activ-
ity, fitness, paediatrics, body composition, genetics,
immunology and biochemistry. Moreover, the study has
been conducted in 5 hospitals from 5 Spanish cities,
respectively (Madrid, Santander, Zaragoza, Pamplona and
Granada). Adaptation of the protocol for 5 different hos-
pitals had as principal advantage that the treatment pro-
gramme potentially will be easier to implement in any
healthcare centre of the Spanish Health Care Service.
Nonetheless, organizing a single educational treatment
for all the centres and the assessment protocols was a
complex process. Training workshops for all the
EVASYON members, who were going to take part in the
programme and in the assessment, were conducted to
unify criteria and to test the methodologies presented in
this article before beginning the study. One pilot group in
each hospital served to solve starting-up problems in the
treatment programme, doubts, human and technical
resources and coordination with adolescents and their
families. Some decisions were also made in the work-
shops on how to send blood samples, protocols of physi-
cal fitness test to carry out in hospitals, possible
postbariatric surgery or follow-up of participants after the
study ended.
The EVASYON study has both strengths and weaknesses.
Several strengths that the EVASYON study presents are as
follows: 1) the sample size achieved of 204 adolescents
with overweight and obesity provides an acceptable statis-
tical power to conduct multivariable analysis (e.g. sex,
maturation status, compliance or not compliance of the
educational therapeutic programme). Few studies per-
formed in clinical settings have recruited, to our knowl-
edge, a greater number of participants than the EVASYON
study [24-26] the duration of the therapeutic programme
is a one-year follow-up, which will make possible to
observe long-term changes resulting from the interven-
tion. In addition, it may reveal the differences that result
between the intensive stage of the treatment and the
extensive stage as reported in previous studies [50]; 3) The
EVASYON study includes the most complete and compre-
hensive assessments of the effectiveness of a weight loss
programme in the individual's physical and psychological
health status. The 9 assessment categories represent a mul-
titude of variables that will be evaluated throughout the
study for being able to determine the most effective
aspects of the intervention, and in which dimensions the
effect of the intervention was the strongest one.
The EVASYON study also involves weaknesses that must
be taken into account: 1) the study does not include a con-
trol group of overweight or obese adolescents. This makes
it difficult to understand the progress, maintenance or
deterioration of the baseline health of participants. Strong
weight loss studies with educational therapeutic pro-
gramme based on physical activity and nutrition have
included control groups [51] or not [52]; 2) an important
dropout due to the duration of the study was detected in
participants and their families. Studies such as the one by
Savoye et al. [51] include 209 subjects who were initially,
recruited; 60% of the whole sample completed 6 months
of treatment and only 53% completed 1-yr follow-up,
obtaining therefore 47% loss of the adolescent partici-
pants during the study; 3) together with the loss of partic-
ipants during the follow-up time, it also caused a loss of
assessments. Participants and their families claimed the
following reasons: forgetfulness, exam periods, inability
to move a family member together with the adolescent,
discouragement.
Initiatives as the EVASYON study contribute to the devel-
opment of the Spanish Strategy for Nutrition, Physical
Activity and the Prevention of Obesity (NAOS Strategy)
initiated in 2005 by the Ministry of Health and Consumer
Affairs [53]. The NAOS Strategy has as main aims to
improve healthy eating and to increase physical activity
levels. Therefore, informative campaigns, agreements with
public and private institutions, voluntary working agree-
ments, educational programmes and supporting health
promotion initiatives are some of the activities carried out
as part of the NAOS Strategy to invert the rate of obesity in
Spanish population with special focus on children. The
NAOS Strategy is in the line of the Global Strategy on Diet,
Physical Activity and Health approved by the World
Health Organization (WHO) in 2004 [54].
In summary, the EVASYON study is an interventional
study assessing the effectiveness of an educational thera-Page 9 of 11
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adolescents with overweight and obesity. The EVASYON
programme attempts to be a national pilot study that may
be implemented as a method of treatment of obesity in
adolescents into the Spanish Health Care Service. This
multidisciplinary and multicenter study assesses changes
in participants for approximately 1-year follow-up over 8
dimensions: 1) diet, 2) physical activity and health-
related physical fitness, 3) psychology, 4) body composi-
tion, 5) haematology, 6) biochemical and metabolic pro-
files, 7) mineral and vitamin profiles, and 8) immunology
profile. Genetic profile was also assessed for examining
the influence of gene-environmental interactions on obes-
ity.
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